General MedicationsORALGeneric
CLOZAPINE
CLOZAPINE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CLOZAPINE is listed in Drugs@FDA under application 209480 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOZAPINE Form and strength TABLET;ORAL - 50MG Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2017-12-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLOZAPINE is listed in Drugs@FDA under application 209480 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOZAPINE Form and strength TABLET;ORAL - 50MG Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2017-12-06 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.